Tefron Statistics

Total Valuation

Tefron has a market cap or net worth of ILS 339.79 million. The enterprise value is 379.21 million.

Market Cap	339.79M
Enterprise Value	379.21M

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Apr 1, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.12%
Shares Change (QoQ)	-5.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.06M

Valuation Ratios

The trailing PE ratio is 6.17.

PE Ratio	6.17
Forward PE	n/a
PS Ratio	0.32
PB Ratio	1.21
P/TBV Ratio	1.36
P/FCF Ratio	4.14
P/OCF Ratio	3.02
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.43, with an EV/FCF ratio of 4.62.

EV / Earnings	6.89
EV / Sales	0.36
EV / EBITDA	3.43
EV / EBIT	4.56
EV / FCF	4.62

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.16.

Current Ratio	1.74
Quick Ratio	0.92
Debt / Equity	0.16
Debt / EBITDA	0.39
Debt / FCF	0.54
Interest Coverage	6.70

Financial Efficiency

Return on equity (ROE) is 21.59% and return on invested capital (ROIC) is 16.61%.

Return on Equity (ROE)	21.59%
Return on Assets (ROA)	9.94%
Return on Invested Capital (ROIC)	16.61%
Return on Capital Employed (ROCE)	26.45%
Revenue Per Employee	541,395
Profits Per Employee	27,841
Employee Count	1,977
Asset Turnover	2.02
Inventory Turnover	4.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.78% in the last 52 weeks. The beta is 0.95, so Tefron's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-15.78%
50-Day Moving Average	2,578.26
200-Day Moving Average	3,052.79
Relative Strength Index (RSI)	35.06
Average Volume (20 Days)	11,594

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tefron had revenue of ILS 1.07 billion and earned 55.04 million in profits. Earnings per share was 4.12.

Revenue	1.07B
Gross Profit	242.14M
Operating Income	84.16M
Pretax Income	71.24M
Net Income	55.04M
EBITDA	103.00M
EBIT	84.16M
Earnings Per Share (EPS)	4.12

Full Income Statement

Balance Sheet

The company has 24.78 million in cash and 44.04 million in debt, giving a net cash position of -19.26 million.

Cash & Cash Equivalents	24.78M
Total Debt	44.04M
Net Cash	-19.26M
Net Cash Per Share	n/a
Equity (Book Value)	279.70M
Book Value Per Share	22.16
Working Capital	167.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 112.58 million and capital expenditures -30.46 million, giving a free cash flow of 82.13 million.

Operating Cash Flow	112.58M
Capital Expenditures	-30.46M
Free Cash Flow	82.13M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.62%, with operating and profit margins of 7.86% and 5.14%.

Gross Margin	22.62%
Operating Margin	7.86%
Pretax Margin	6.66%
Profit Margin	5.14%
EBITDA Margin	9.62%
EBIT Margin	7.86%
FCF Margin	7.67%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 0.03%.

Dividend Per Share	0.60
Dividend Yield	0.03%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	13.20%
Buyback Yield	-3.12%
Shareholder Yield	-3.10%
Earnings Yield	16.20%
FCF Yield	24.17%

Dividend Details

Stock Splits

The last stock split was on January 22, 2009. It was a reverse split with a ratio of 0.1.

Last Split Date	Jan 22, 2009
Split Type	Reverse
Split Ratio	0.1

Scores

Tefron has an Altman Z-Score of 3.06.

Altman Z-Score	3.06
Piotroski F-Score	n/a